UNC Metastatic Cancer Radiation Therapy Registry

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID
NCT06306924
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Metastatic Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Radiation therapy — RADIATION
    Subjects with metastatic cancer receive radiation therapy.

Study Details

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

Key Dates

Start date
Apr 21, 2024
Status verified
Apr 2026
Primary completion
May 31, 2033
Completion
May 31, 2033

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Palliative radiation therapy
    Subjects who are with metastatic cancer receive palliative radiation therapy.

Primary Outcome Measure

Clinical Data [ Time Frame: Up to 1 month ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel HillChapel HillNorth Carolina27599
Shivani Sud, MS
[email protected]
919-918-5924
Shivani Sud, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chapel Hill, NC

By research site
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill· Chapel Hill, NC

Related Studies